Arsenic trioxide inhibits the growth of human gall bladder carcinoma cell and its effect on the cyclin D1

Yuexin LING; Zhilong AI; Tao SUO; Zhenbin SHEN; Saixiong TONG.
China Oncology ; (12)2006.
Artículo en Zh | WPRIM | ID: wpr-545612

Documentos relacionados

  1. Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide-Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C.
  2. [Effects of arsenic trioxide on migration, invasion and apoptosis of hepatocellular carcinoma HepG2 cells].
  3. [Synergistic Killing Effects of Arsenic Trioxide Combined with Itraconazole on KG1a Cells].
  4. An Efficient Synthesis of Novel Dextran-Arsenite Nanoparticles intended for Potential Antitumor Drug Material.
  5. miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
  6. Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer.
  7. The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity.
  8. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells.
  9. Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia.
  10. [Effects of Arsenic Trioxide on Cdc20 and Mad2 in Acute Myeloid Leukemia HL-60 Cell Line].